Literature DB >> 16925594

The anxiety-like phenotype of 5-HT receptor null mice is associated with genetic background-specific perturbations in the prefrontal cortex GABA-glutamate system.

S Bruening1, E Oh, A Hetzenauer, S Escobar-Alvarez, R I Westphalen, H C Hemmings, N Singewald, T Shippenberg, M Toth.   

Abstract

A deficit in the serotonin 5-HT(1A) receptor has been found in panic and post-traumatic stress disorders, and genetic inactivation of the receptor results in an anxiety-like phenotype in mice on both the C57Bl6 and Swiss-Webster genetic backgrounds. Anxiety is associated with increased neuronal activity in the prefrontal cortex and here we describe changes in glutamate and GABA uptake of C57Bl6 receptor null mice. Although these alterations were not present in Swiss-Webster null mice, we have previously reported reductions in GABA(A) receptor expression in these but not in C57Bl6 null mice. This demonstrates that inactivation of the 5-HT(1A) receptor elicits different and genetic background-dependent perturbations in the prefrontal cortex GABA/glutamate system. These perturbations can result in a change in the balance between excitation and inhibition, and indeed both C57Bl6 and Swiss-Webster null mice show signs of increased neuronal excitability. Because neuronal activity in the prefrontal cortex controls the extent of response to anxiogenic stimuli, the genetic background-specific perturbations in glutamate and GABA neurotransmission in C57Bl6 and Swiss-Webster 5-HT(1A) receptor null mice may contribute to their shared anxiety phenotype. Our study shows that multiple strains of genetically altered mice could help us to understand the common and individual features of anxiety.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16925594     DOI: 10.1111/j.1471-4159.2006.04129.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Neuronal long-range temporal correlations and avalanche dynamics are correlated with behavioral scaling laws.

Authors:  J Matias Palva; Alexander Zhigalov; Jonni Hirvonen; Onerva Korhonen; Klaus Linkenkaer-Hansen; Satu Palva
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

2.  Decreased GABAA receptor binding in the medullary serotonergic system in the sudden infant death syndrome.

Authors:  Kevin G Broadbelt; David S Paterson; Richard A Belliveau; Felicia L Trachtenberg; Elisabeth A Haas; Christina Stanley; Henry F Krous; Hannah C Kinney
Journal:  J Neuropathol Exp Neurol       Date:  2011-09       Impact factor: 3.685

3.  Dysregulation of the axonal trafficking of nuclear-encoded mitochondrial mRNA alters neuronal mitochondrial activity and mouse behavior.

Authors:  Amar N Kar; Ching-Yu Sun; Kathryn Reichard; Noreen M Gervasi; James Pickel; Kazu Nakazawa; Anthony E Gioio; Barry B Kaplan
Journal:  Dev Neurobiol       Date:  2013-11-20       Impact factor: 3.964

Review 4.  The Serotonin Brainstem Hypothesis for the Sudden Infant Death Syndrome.

Authors:  Hannah C Kinney; Robin L Haynes
Journal:  J Neuropathol Exp Neurol       Date:  2019-09-01       Impact factor: 3.685

Review 5.  Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Authors:  Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2008-03-26       Impact factor: 8.989

6.  Comparisons of mass spectrometry compatible surfactants for global analysis of the mammalian brain proteome.

Authors:  Emily I Chen; Daniel McClatchy; Sung Kyu Park; John R Yates
Journal:  Anal Chem       Date:  2008-10-21       Impact factor: 6.986

7.  Mice deficient in the alpha subunit of G(z) show changes in pre-pulse inhibition, anxiety and responses to 5-HT(1A) receptor stimulation, which are strongly dependent on the genetic background.

Authors:  Maarten van den Buuse; Sally Martin; Joan Holgate; Klaus Matthaei; Ian Hendry
Journal:  Psychopharmacology (Berl)       Date:  2007-08-09       Impact factor: 4.530

Review 8.  Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.

Authors:  Pau Celada; Analía Bortolozzi; Francesc Artigas
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

Review 9.  Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience.

Authors:  John H Krystal; Alexander Neumeister
Journal:  Brain Res       Date:  2009-03-28       Impact factor: 3.252

10.  Pharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situation.

Authors:  Yan Clément; Anne-Marie Le Guisquet; Patrice Venault; Georges Chapouthier; Catherine Belzung
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.